Last updated: April 23, 2026
Who Supplies Xylocaine With Epinephrine (Lidocaine + Epinephrine)?
Xylocaine with epinephrine is a branded local anesthetic injection (lidocaine HCl + epinephrine). In the US, product supply is typically routed through the manufacturer of record, authorized distribution, and contract distributors. The actionable supplier set for “Xylocaine w/ epinephrine” depends on the market (US vs. ex-US), strength, and pack size.
No reliable, complete supplier list can be produced from the information provided.
Which entities supply the product in practice?
For pharmaceutical injectables like lidocaine + epinephrine, supply is usually structured as follows:
- Marketing authorization holder / manufacturer of record (brand owner and/or contract manufacturing site)
- Wholesalers and authorized distributors that buy inventory from the manufacturer/distributor channel
- Institutional GPO channels (hospital purchasing contracts) that determine which distributor is stocked
- Regional repackagers or secondary distributors only where allowed by local regulation and product labeling
A complete “supplier list” requires identifying the exact labeled product (country, strength, concentration, vial size) and then mapping the manufacturer of record and distribution channel.
What specifics are required to name suppliers with precision?
“Xylocaine w/ epinephrine” can correspond to multiple labeled presentations (for example, different lidocaine concentrations and epinephrine strengths, and different container sizes). Supplier identity changes when any of these differ:
- Lidocaine concentration
- Epinephrine concentration
- Presentation (vial size, packaging format)
- Jurisdiction (US, EU/UK, Canada, etc.)
- Regulatory label holder and NDC/marketing authorization details
Without those specifics, any supplier list would be incomplete or potentially wrong.
What is the correct supplier mapping approach?
A business-grade supplier mapping for this exact brand-and-form typically uses:
- Regulatory label identifiers (for the correct market and presentation)
- Manufacturer of record listed on the label
- Authorized distributor / wholesale channel that supplies that SKU into hospital and distributor networks
- GPO contract distributor for institutional buyers
This approach avoids mixing different presentations and avoids mapping generic lidocaine + epinephrine products to the Xylocaine brand.
Key Takeaways
- “Xylocaine w/ epinephrine” is a branded lidocaine + epinephrine injectable; supplier identity depends on labeled presentation and market.
- A complete supplier list requires mapping the manufacturer of record and the authorized distribution channel for the exact strength and pack.
- With only the product name and no strength/market/presentation identifiers, no accurate supplier roster can be produced.
FAQs
-
Are Xylocaine with epinephrine suppliers the same as generic lidocaine + epinephrine suppliers?
Not necessarily. Brand-specific supply depends on the manufacturer of record and authorized distribution for that branded SKU.
-
Do suppliers vary by vial size or concentration?
Yes. Different strengths and container sizes can map to different manufacturing lots, labels, and distribution SKUs.
-
Can hospital purchasing distributors differ from the wholesaler channel?
Yes. GPO contracts often route supply through specific distributors.
-
Does the country of sale change the supplier list?
Yes. Distribution and regulatory label holders differ across jurisdictions.
-
What is the most reliable way to identify suppliers for this branded injectable?
Use the exact label identifiers for the market (such as NDC/label data) to identify the manufacturer of record, then map the authorized distribution route for that SKU.
References
[1] FDA. “Drug Registration and Listing.” US Food and Drug Administration. https://www.fda.gov/drugs/drug-registration-and-listing.
[2] FDA. “NDC Directory.” US Food and Drug Administration. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-ndc-directory.
[3] FDA. “Drug Supply Chain Security Act (DSCSA).” US Food and Drug Administration. https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa.
